Understanding and addressing geography-related variability in referral pathways and NAC for TN and HER2+ breast cancer—for which local referral pathways, clinician knowledge and practice patterns, and resource availability may be underlying mechanisms—should be prioritized to improve the design of cancer systems. The gene discussed is ERBB2; the disease is cancer.